Advanced search
Publication Cover
Acta Cardiologica Volume 69, 2014 - Issue 2
Submit an article Journal homepage
17
Views
2
CrossRef citations to date
0
Altmetric
Articles

Study of coronary artery perforation during percutaneous coronary intervention in the Cangzhou Chinese population

Yongxing LiuDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.Correspondence[email protected]
, MM,
Zesheng XuDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Wanzhong PengDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Zhiyuan SongDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Zengcai MaDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Bingxun WangDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Jiangang ZhangDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Shipeng DaiDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM,
Tao GengDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM &
Yonggang YuanDept. of Cardiology, Cangzhou Central Hospital, Cangzhou, China.
, MM show all
Pages 139-143 | Received 07 Sep 2013, Accepted 25 Nov 2013, Published online: 23 May 2017

References

  • Javaid A, Buch AN, Satler LF, Kent KM, Suddath WO, Lindsay J, Jr., Pichard AD, Waksman R. Management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2006; 98: 911–4.
  • Gunning MG, Williams IL, Jewitt DE, Shah AM, Wainwright RJ, Thomas MR. Coronary artery perforation during percutaneous intervention: incidence and outcome. Heart 2002; 88:495–8.
  • Ramana RK, Arab D, Joyal D, Steen L, Cho L, Lewis B, Liu J, Loeb H, Leya F. Coronary artery perforation during percutaneous coronary intervention: incidence and outcomes in the new interventional era. J Invasive Cardiol 2005; 17: 603–5.
  • Dippel EJ, Kereiakes DJ, Tramuta DA, BroderickTM, Shimshak TM, Roth EM, Hattemer CR, Runyon JP, Whang DD, Schneider JF, Abbottsmith CW. Coronary perforation during percutaneous coronary intervention in the era of abciximab platelet glycoprotein iib/iiia blockade: an algorithm for percutaneous management. Catheter Cardiovasc Interv 2001; 52:279–86.
  • Fasseas P. Orford JL, Panetta CJ, Bell MR, Denlctas AE, Lennon RJ, Holmes DR, Berger PB. Incidence, correlates, management, and clinical outcome of coronary perforation: analysis of 16,298 procedures. Am Heart J 2004; 147: 140–5.
  • Shimony A, Zahger D, Van Straten M, Shalev A, Gilutz H, Ilia R, Cafri C. Incidence, risk factors, management and outcomes of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2009; 104: 1674–7.
  • Hendry C, Fraser D, EichhoferJ, Mamas MA, Fath-Ordoubadi F, El-Omar M, Williams P. Coronary perforation in the drug-eluting stent era: incidence, risk factors, management and outcome: the UK experience. Eurolntervention 2012; 8: 79–86.
  • Gruberg L, Pinnow E, Flood R, Bonnet Y, Tebeica M, Waksman R, Satler LF, Pichard AD, Kent KM, Leon MB, Lindsay J, Jr. Incidence, management, and outcome of coronary artery perforation during percutaneous coronary intervention. Am J Cardiol 2000; 86: 680-2, A8.
  • Fukutomi T, Suzuki T, Popma JJ, Hosokawa H, Yokoya K, lnada T, Hayase M, Kondo H, Ito 5, Suzuki 5, Itoh M. Early and late clinical outcomes following coronary perforation in patients undergoing percutaneous coronary intervention. Circ J 2002; 66: 349–56.
  • Stankovic G, Orlic D, Corvaja N, Airoldi F, Chieffo A, Spanos V. Montorfano M, Carlino M, Finci L, Sangiorgi G, Colombo A. Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations. Am J Cardiol 2004; 93:213–6.
  • Ellis SG, Ajluni 5, Arnold AZ, Popma JJ, Bittl JA, Eigler NL, Cowley MJ, Raymond RE, Safian RD, Whitlow PL Increased coronary perforation in the new device era. Incidence, classification, management, and outcome. Circulation 1994; 90: 2725–30.
  • Zhang M, Kang WC, Moon Cl, Han SH, Ahn TH, Shin EK. Coronary artery perforation following implantation of a drug-eluting stent rescued by deployment of a covered stent in symptomatic myocardial bridging. Korean Circ J 2010; 40: 148–51.
  • Jokhi PP, McKenzie DB, O’Kane P. Use of a novel pericardial covered stent to seal an iatrogenic coronary perforation. J Invasive Cardiol 2009; 21: E187–190.
  • Cordero H, Gupta N, Underwood PL, Gogte ST, Heuser RR. Intracoronary autologous blood to seal a coronary perforation. Herz 2001; 26: 157–60.
  • Oda H, Oda M, Makiyama Y, Kashimura T, Takahashi K, Miida T, Higuma N. Guidewire-induced coronary artery Perforation treated with transcatheter delivery of subcutaneous tissue. Catheter Cardiovasc Interv 2005; 66: 369–74.
  • Yasuoka Y, Sasaki T. Successful collapse vessel treatment with a syringe for thrombus-aspiration after the guidewire-induced coronary artery perforation. Cardiovasc Revasc Med 2010; 11: 263.e1–3.
  • Rog uin A, Beyar R. Coronary perforation 2006—watch for the wire. J Invasive Cardiol 2005; 17:606–8.
  • Ly H, Awaida JP, Lesperance J, Bilodeau L. Angiographic and clinical outcomes of polytetrafluoroethylene-covered stent use in significant coronary perforations. Am J Cardiol 2005; 95: 244–6.
  • Yeo KK, Rogers JH, Laird JR. Use of stent grafts and coils in vessel rupture and perforation. J Interv Cardiol 2008; 21: 86–99.
  • Simon C, Roscitano A, Capuano F, Bianchini R, Tonelli E, Sinatra R. Emergency repair of coronary perforation following percutaneous transluminal coronary angioplasty failure: a high-risk choice? J Cardiovasc Med (Hagerstown) 2006; 7: 365–7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

A worldwide pioneer in biotechnology.
Novartis. Your partner in Heart Failure & Atherosclerosis >>

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.